Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × fludarabine × Clear all

NCT03648697 2020-08-11

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Phase 2 Unknown

Nasopharyngeal Carcinoma